Consistent Growth in Biotech
GreyRigge Associates continues to expand, adding breadth of capability and depth of skills to our portfolio of consulting services. We have done this through a carefully considered strategic plan bringing in top talent across the world whilst opening new offices and territories to meet the needs of our global clients.
During 2023 we opened our North America office in Cambridge, Massachusetts and followed that in 2024 with the opening our Japan office in the city of Kobe. Coupled with our expanded UK operation, near London, we are exceptionally placed to support thriving local biotech hubs at all stages of biopharmaceutical research, development and production. This global footprint ensures that we can sit alongside local client teams and deliver a consistent level of high-value consultancy.
Our expansion makes us one of the few one-stop, follow-the-sun global biotech consultancies, able to meet the diverse needs and expectations of global clients. We pride ourselves on delivering the services and deliverables where and when you need.
